The Efficacy and Safety of Lubiprostone for Constipation in Cancer Patients Compared with Non-cancer Patients: A Retrospective Cohort Study.

Author: EsumiSatoru, KajizonoMakoto, KitamuraYoshihisa, SadaHikaru, SendoToshiaki, UshioSouichiro

Paper Details 
Original Abstract of the Article :
Lubiprostone is an effective drug for various types of constipation in patients without cancer; however, there is no report on its efficacy and safety in patients with cancer. Our purpose was to evaluate the efficacy and safety of lubiprostone for constipation in cancer patients. We retrospectively ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1248/bpb.b20-00398

データ提供:米国国立医学図書館(NLM)

Lubiprostone: A Beacon of Hope for Constipation in Cancer Patients?

Imagine a desert of digestive discomfort, where constipation can be a common and debilitating side effect for cancer patients. This retrospective cohort study explores the efficacy and safety of lubiprostone, a medication commonly used to treat constipation, in cancer patients. The researchers compared the effects of lubiprostone in cancer patients to those in non-cancer patients, hoping to find an oasis of relief in this desert of digestive distress.

Navigating the Desert of Constipation: Exploring the Efficacy of Lubiprostone in Cancer Patients

The study found that lubiprostone was effective in increasing bowel movements in both cancer and non-cancer patients. However, the authors noted a higher incidence of diarrhea and nausea in cancer patients, suggesting that lubiprostone might have a more pronounced effect in this population. They also found that cancer patients with a low body mass index (BMI) were more likely to discontinue lubiprostone due to side effects. These findings highlight the need to carefully consider individual patient characteristics when prescribing lubiprostone for constipation, especially in those with cancer.

Finding Relief: Navigating the Balance Between Benefits and Risks

This study suggests that lubiprostone can be a valuable tool for managing constipation in cancer patients. However, it is important to weigh the potential benefits against the risk of side effects. Healthcare professionals should carefully monitor patients taking lubiprostone for constipation, particularly those with a low BMI, to minimize the risk of adverse effects.

Dr. Camel's Conclusion

This study, like a camel caravan seeking a safe passage through a desert of constipation, explores the potential of lubiprostone for cancer patients. The findings suggest that this medication can be effective, but it's important to be aware of the potential side effects. Careful monitoring and individualization of treatment are essential for maximizing benefits and minimizing risks.

Date :
  1. Date Completed 2021-07-16
  2. Date Revised 2021-07-16
Further Info :

Pubmed ID

33132315

DOI: Digital Object Identifier

10.1248/bpb.b20-00398

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.